Clinical trial
Testosterone Treatment for Multiple Sclerosis
NCT00405353 · University of California, Los Angeles, Other · Completed
Key facts
| NCT number | NCT00405353 |
|---|---|
| Title | Testosterone Treatment for Multiple Sclerosis |
| Official title | Testosterone Treatment for Multiple Sclerosis: A Preliminary Trial |
| Lead sponsor | University of California, Los Angeles, Other |
| Collaborators | National Multiple Sclerosis Society |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Androgel 10 grams of gel containing 100 mg of testosterone |
| Enrollment | 10 |
| Start date | Apr 1, 2002 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Nov 30, 2006 |
| Last update posted | Nov 22, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: